215 filings
6-K
IPHA
Innate Pharma
21 Mar 24
Summary of Consolidated Financial Statements and Notes
9:20am
6-K
IPHA
Innate Pharma
21 Mar 24
Innate Pharma reports Full Year 2023 Financial Results and Business Update
6:01am
6-K
IPHA
Innate Pharma
19 Mar 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:33am
6-K
IPHA
Innate Pharma
14 Mar 24
Innate Pharma Announces Conference Call And Webcast For Full Year 2023 Financial Results
7:00am
6-K
IPHA
Innate Pharma
6 Mar 24
Current report (foreign)
6:00am
6-K
d9hh 5qe6
6 Mar 24
Current report (foreign)
6:00am
6-K
cjij3q5x
21 Feb 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:00am
6-K
wriq5 4fa18ct4q
6 Feb 24
Current report (foreign)
5:05pm
424B5
khqi g20i3xj
6 Feb 24
Prospectus supplement for primary offering
5:00pm
EFFECT
wjm5a1o
17 Jan 24
Notice of effectiveness
12:15am
6-K
dy2t1tvp0lc8g5mj6r
12 Jan 24
Innate Pharma S.a. 6-K
6:00am
CORRESP
2ts443kre wvxp9cah
11 Jan 24
Correspondence with SEC
12:00am
6-K
h7swp
5 Jan 24
Innate Pharma S.a. 6-K
6:09am
6-K
dndmr xzb5evtyu8h
4 Jan 24
FDA lifts partial clinical hold on lacutamab clinical programFatal case related to disease progression and unrelated to the treatment
6:01am
6-K
vov6uqwt0
4 Jan 24
Innate Pharma 6-K
6:00am
UPLOAD
2na2t
26 Dec 23
Letter from SEC
12:00am
F-3
r2rb8l x4m
20 Dec 23
Shelf registration (foreign)
4:45pm
6-K
zcgyr
20 Dec 23
Current report (foreign)
4:30pm
6-K
zkvkrjejdr zkk
19 Dec 23
Innate Pharma S.a. 6-K
6:00am
6-K
viht6n1yeulxkxig81c
18 Dec 23
Innate Pharma S.a. 6-K
11:40am